WebDisclosure WebDisclosure
Basculer en Français
10604 Companies
225013 Keywords
153734 Articles
119072 Press releases
Headlines Articles Press releases Moderna, Inc. Remove
  1. Home
  2. Companies
  3. Moderna, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/30/2023 at 13:15, 3 years 4 months ago

    Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/17/2023 at 22:05, 3 years 5 months ago

    Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/09/2023 at 13:00, 3 years 5 months ago

    Moderna Announces Advances Across mRNA Pipeline and Provides Business Update

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/05/2023 at 22:05, 3 years 5 months ago

    Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

    Logo of Moderna, Inc.
Previous page
1 ... 33 34
Accesswire
  • Published on 06/20/2026 at 01:00, 22 hours 19 minutes ago

    Onco-Innovations Announces Non-Brokered LIFE Offering

  • Published on 06/20/2026 at 00:00, 23 hours 19 minutes ago

    Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

  • Published on 06/19/2026 at 04:30, 1 day 18 hours ago

    Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp

  • Published on 06/19/2026 at 01:20, 1 day 21 hours ago

    American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting

  • Published on 06/19/2026 at 01:07, 1 day 22 hours ago

    Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE
EQS Group
  • Published on 06/20/2026 at 21:25, 1 hour 54 minutes ago

    VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS

  • Published on 06/20/2026 at 06:00, 17 hours 19 minutes ago

    Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong

  • Published on 06/19/2026 at 20:17, 1 day 3 hours ago

    2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations

  • Published on 06/19/2026 at 20:17, 1 day 3 hours ago

    2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité

  • Published on 06/19/2026 at 19:01, 1 day 4 hours ago

    Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

View all EQS
Les Echos
  • Published on 06/19/2026 at 19:33, 1 day 3 hours ago

    Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026

  • Published on 06/19/2026 at 19:33, 1 day 3 hours ago

    Disclosure of transactions in own shares from June 15 to June 19, 2026

  • Published on 06/19/2026 at 19:23, 1 day 3 hours ago

    Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

  • Published on 06/19/2026 at 19:23, 1 day 3 hours ago

    Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026

  • Published on 06/19/2026 at 19:05, 1 day 4 hours ago

    CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy